Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C11orf42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRODH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGF2-AS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SAMD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAM7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLEK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLIP1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GATA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC100128653 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CROCC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C22orf15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GABRD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUNX1T1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSKS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC400620 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on